Limits...
Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart.

Malliaras K, Zhang Y, Seinfeld J, Galang G, Tseliou E, Cheng K, Sun B, Aminzadeh M, Marbán E - EMBO Mol Med (2013)

Bottom Line: After MI, new cardiomyocytes arise from both progenitors as well as pre-existing cardiomyocytes.Transplantation of CDCs upregulates host cardiomyocyte cycling and recruitment of endogenous progenitors, while boosting heart function and increasing viable myocardium.The observed phenomena cannot be explained by cardiomyocyte polyploidization, bi/multinucleation, cell fusion or DNA repair.

View Article: PubMed Central - PubMed

Affiliation: Cedars-Sinai Heart Institute, Los Angeles, CA, USA.

Show MeSH

Related in: MedlinePlus

Resident cardiomyocyte turnover in the adult mouse heart assessed by immunocytochemistryA–C. Immunocytochemistry of enzymatically dissociated cardiomyocytes for GFP, αSA and BrdU (A), Ki67 (B), H3P (C) reveals that the young adult heart contains a small pool of cycling resident cardiomyocytes that increases after MI and is upregulated by CDC therapy. Arrows in (C) show an example of karyokinesis (*p < 0.05 compared to sham, MI, #p < 0.05 compared to sham only, n = 3/group/timepoint). All error bars represent SDs. One-way ANOVA followed by LSD post hoc test was used for statistical analysis (A: CDCs vs sham: 1w p < 0.001, 2w p < 0.001, 3w p = 0.001, 4w p < 0.001, 5w p < 0.001; CDCs vs MI: 1w p = 0.001, 2w p < 0.001, 3w p = 0.003, 4w p < 0.001, 5w p = 0.001; B: CDCs vs sham: 1w p = 0.006, 2w p = 0.005, 3w p = 0.008; CDCs vs MI: 1w p = 0.027, 2w p = 0.021, 3w p = 0.046; C: MI vs sham 2w p = 0.020; CDCs vs sham: 1w p = 0.009, 2w p < 0.001, 3w p = 0.011; CDCs vs MI: 1w p = 0.038, 2w p = 0.003, 3w p = 0.046; all other p = ns). All scale bars: 10 µm.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3569637&req=5

fig03: Resident cardiomyocyte turnover in the adult mouse heart assessed by immunocytochemistryA–C. Immunocytochemistry of enzymatically dissociated cardiomyocytes for GFP, αSA and BrdU (A), Ki67 (B), H3P (C) reveals that the young adult heart contains a small pool of cycling resident cardiomyocytes that increases after MI and is upregulated by CDC therapy. Arrows in (C) show an example of karyokinesis (*p < 0.05 compared to sham, MI, #p < 0.05 compared to sham only, n = 3/group/timepoint). All error bars represent SDs. One-way ANOVA followed by LSD post hoc test was used for statistical analysis (A: CDCs vs sham: 1w p < 0.001, 2w p < 0.001, 3w p = 0.001, 4w p < 0.001, 5w p < 0.001; CDCs vs MI: 1w p = 0.001, 2w p < 0.001, 3w p = 0.003, 4w p < 0.001, 5w p = 0.001; B: CDCs vs sham: 1w p = 0.006, 2w p = 0.005, 3w p = 0.008; CDCs vs MI: 1w p = 0.027, 2w p = 0.021, 3w p = 0.046; C: MI vs sham 2w p = 0.020; CDCs vs sham: 1w p = 0.009, 2w p < 0.001, 3w p = 0.011; CDCs vs MI: 1w p = 0.038, 2w p = 0.003, 3w p = 0.046; all other p = ns). All scale bars: 10 µm.

Mentions: Flow cytometry of BrdU and Ki67 in FACS-sorted GFP+ cardiomyocytes revealed that the normal heart contains a small fraction of cycling endogenous cardiomyocytes (BrdU+: 0.08 ± 0.05% after the 1st week of BrdU pulsing, 0.4 ± 0.12% after 5 weeks of BrdU pulsing; Ki67+: 0.04 ± 0.03%). The low but measurable rate of basal cycling is consistent with some reports of cardiomyocyte turnover in the young adult heart (Bergmann et al, 2009; Soonpaa & Field, 1997), but not others (Kajstura et al 2010; Walsh et al, 2010). Tissue injury results in increased cardiomyocyte cycling, primarily during the first 3 weeks post-MI (BrdU+: 0.27 ± 0.09% after the 1st week of BrdU pulsing, 0.74 ± 0.05% after 5 weeks of BrdU pulsing; Ki67+: 0.14 ± 0.03%). Both the low rate of cardiomyocyte cycling under basal conditions, as well as the increase after injury, are notable. However, the most surprising finding is the amplification of cardiomyocyte cycling by cell therapy: the number of BrdU-incorporating preformed cardiomyocytes increases approximately threefold relative to MI (and approximately ninefold over basal levels) to 0.73 ± 0.11% after the 1st week of BrdU pulsing (2.09 ± 0.12% after 5 weeks of BrdU pulsing). Likewise, the Ki67+ percentage rises to 0.43 ± 0.09% 1 week after CDC administration (Fig 2A–D, Supporting Information Fig 2). The differences were greatest in the first 3 weeks post-injury. Immunocytochemistry of enzymatically dissociated cardiomyocytes (GFP+, αSA+) for BrdU, Ki67 and H3P (a marker of karyokinesis) confirmed these results (Fig 3).


Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart.

Malliaras K, Zhang Y, Seinfeld J, Galang G, Tseliou E, Cheng K, Sun B, Aminzadeh M, Marbán E - EMBO Mol Med (2013)

Resident cardiomyocyte turnover in the adult mouse heart assessed by immunocytochemistryA–C. Immunocytochemistry of enzymatically dissociated cardiomyocytes for GFP, αSA and BrdU (A), Ki67 (B), H3P (C) reveals that the young adult heart contains a small pool of cycling resident cardiomyocytes that increases after MI and is upregulated by CDC therapy. Arrows in (C) show an example of karyokinesis (*p < 0.05 compared to sham, MI, #p < 0.05 compared to sham only, n = 3/group/timepoint). All error bars represent SDs. One-way ANOVA followed by LSD post hoc test was used for statistical analysis (A: CDCs vs sham: 1w p < 0.001, 2w p < 0.001, 3w p = 0.001, 4w p < 0.001, 5w p < 0.001; CDCs vs MI: 1w p = 0.001, 2w p < 0.001, 3w p = 0.003, 4w p < 0.001, 5w p = 0.001; B: CDCs vs sham: 1w p = 0.006, 2w p = 0.005, 3w p = 0.008; CDCs vs MI: 1w p = 0.027, 2w p = 0.021, 3w p = 0.046; C: MI vs sham 2w p = 0.020; CDCs vs sham: 1w p = 0.009, 2w p < 0.001, 3w p = 0.011; CDCs vs MI: 1w p = 0.038, 2w p = 0.003, 3w p = 0.046; all other p = ns). All scale bars: 10 µm.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3569637&req=5

fig03: Resident cardiomyocyte turnover in the adult mouse heart assessed by immunocytochemistryA–C. Immunocytochemistry of enzymatically dissociated cardiomyocytes for GFP, αSA and BrdU (A), Ki67 (B), H3P (C) reveals that the young adult heart contains a small pool of cycling resident cardiomyocytes that increases after MI and is upregulated by CDC therapy. Arrows in (C) show an example of karyokinesis (*p < 0.05 compared to sham, MI, #p < 0.05 compared to sham only, n = 3/group/timepoint). All error bars represent SDs. One-way ANOVA followed by LSD post hoc test was used for statistical analysis (A: CDCs vs sham: 1w p < 0.001, 2w p < 0.001, 3w p = 0.001, 4w p < 0.001, 5w p < 0.001; CDCs vs MI: 1w p = 0.001, 2w p < 0.001, 3w p = 0.003, 4w p < 0.001, 5w p = 0.001; B: CDCs vs sham: 1w p = 0.006, 2w p = 0.005, 3w p = 0.008; CDCs vs MI: 1w p = 0.027, 2w p = 0.021, 3w p = 0.046; C: MI vs sham 2w p = 0.020; CDCs vs sham: 1w p = 0.009, 2w p < 0.001, 3w p = 0.011; CDCs vs MI: 1w p = 0.038, 2w p = 0.003, 3w p = 0.046; all other p = ns). All scale bars: 10 µm.
Mentions: Flow cytometry of BrdU and Ki67 in FACS-sorted GFP+ cardiomyocytes revealed that the normal heart contains a small fraction of cycling endogenous cardiomyocytes (BrdU+: 0.08 ± 0.05% after the 1st week of BrdU pulsing, 0.4 ± 0.12% after 5 weeks of BrdU pulsing; Ki67+: 0.04 ± 0.03%). The low but measurable rate of basal cycling is consistent with some reports of cardiomyocyte turnover in the young adult heart (Bergmann et al, 2009; Soonpaa & Field, 1997), but not others (Kajstura et al 2010; Walsh et al, 2010). Tissue injury results in increased cardiomyocyte cycling, primarily during the first 3 weeks post-MI (BrdU+: 0.27 ± 0.09% after the 1st week of BrdU pulsing, 0.74 ± 0.05% after 5 weeks of BrdU pulsing; Ki67+: 0.14 ± 0.03%). Both the low rate of cardiomyocyte cycling under basal conditions, as well as the increase after injury, are notable. However, the most surprising finding is the amplification of cardiomyocyte cycling by cell therapy: the number of BrdU-incorporating preformed cardiomyocytes increases approximately threefold relative to MI (and approximately ninefold over basal levels) to 0.73 ± 0.11% after the 1st week of BrdU pulsing (2.09 ± 0.12% after 5 weeks of BrdU pulsing). Likewise, the Ki67+ percentage rises to 0.43 ± 0.09% 1 week after CDC administration (Fig 2A–D, Supporting Information Fig 2). The differences were greatest in the first 3 weeks post-injury. Immunocytochemistry of enzymatically dissociated cardiomyocytes (GFP+, αSA+) for BrdU, Ki67 and H3P (a marker of karyokinesis) confirmed these results (Fig 3).

Bottom Line: After MI, new cardiomyocytes arise from both progenitors as well as pre-existing cardiomyocytes.Transplantation of CDCs upregulates host cardiomyocyte cycling and recruitment of endogenous progenitors, while boosting heart function and increasing viable myocardium.The observed phenomena cannot be explained by cardiomyocyte polyploidization, bi/multinucleation, cell fusion or DNA repair.

View Article: PubMed Central - PubMed

Affiliation: Cedars-Sinai Heart Institute, Los Angeles, CA, USA.

Show MeSH
Related in: MedlinePlus